On September 19, a letter signed by 45 members of the U.S. House of Representatives will be delivered to U.S. Drug Enforcement Administration (DEA) Administrator Karen Tandy urging her agency to license …
On July 12, in the new Congress’s first oversight hearing on the federal government’s role regarding medical marijuana, Reps. Bobby Scott (D-VA) and Jerrold Nadler (D-NY) grilled officials …
American Medical Students Association California Medical Association Lymphoma Foundation of America Multiple Sclerosis Foundation National Association for Public Health Policy New Mexico Nurses Association …
Prof. Craker, assisted by a great legal team led by Julie Carpenter, Jenner & Block, Allen Hopper, ACLU, and Emanuel Jacobowitz, Steptoe & Johnson, and including Christina Alvarez, ACLU and Lauren …
The Sacramento Bee published an excellent op-ed by Claire Cooper entitled, "Rejected in Court, Medical Pot Advocates Turn to DEA." The op-ed is an excellent summary of the legal and political …
DEA Attorney Charles Trant submitted DEA’s “exception” to the February 12, 2007 opinion of ALJ Bittner. Trant objected to ALJ Bittner’s recommendation that it would be in the public …
The DEA’s lawyers have requested requested an extra 20 days to file their objections to the Judge’s decision. In doing so, they also granted MAPS’ lawyers an additional 20 days. This …
Contact Jag Davies, MAPS Director of Communications (831) 336-4325 or jag@maps.org For Immediate Release February 13, 2007 DEA Judge Recommends End to Government Obstruction of Medical Marijuana Research …
Today, a final brief (PDF) was submitted to DEA Administrative Law Judge (ALJ) Mary Ellen Bittner by lawyers for Prof. Lyle Craker a final brief was submitted to DEA Administrative Law Judge (ALJ) Mary …
On April 28, 2006, a letter to FDA was sent by 24 Members of Congress asking for the scientific basis of the recent statement by FDA on the medicinal potential of marijuana.
The FDA’s statement on the medicinal potential of marijuana, issued April 20, 2006, generated a number of editorial criticisms: April 22, 2006: The New York Times April 23, 2006: The Chicago Tribune …
The FDA issued a statement indicating that marijuana had no currently accepted medical uses. Stories in the New York Times, the Washington Post, and the Associated Press reported on this statement and …
